Alpha-Tocopherol

Alpha-Tocopherol

SCHEMBL360251

Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2.O=C(O)CCCC(=O)O

nearest known ligand 0.84

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.84
TTPA P49638 3/20 0.84
MAPT P10636 2/20 0.84
MEN1 O00255 2/20 0.84
KMT2A Q03164 2/20 0.84
GSTP1 P09211 1/20 0.84
USP2 O75604 1/20 0.84
THRB P10828 1/20 0.84
CYP2C9 P11712 1/20 0.84
CYP2C19 P33261 1/20 0.84
ALOX5 P09917 3/20 0.76
NR1I2 O75469 2/20 0.76
GSTO1 P78417 2/20 0.72
PTPN1 P18031 1/20 0.72
PSEN1 P49768 2/20 0.69
PDE4A P27815 1/20 0.66
PDE3A Q14432 1/20 0.66
AKT1 P31749 2/20 0.50
PDPK1 O15530 1/20 0.50
PHLPP1 O60346 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alpha-Tocopherol SCHEMBL27697040 1.00 LMNA (0.84) LMNATTPAMAPTMEN1KMT2A
Alpha-Tocopherol SCHEMBL3950296 0.98 LMNA (0.84) LMNATTPAMAPTMEN1KMT2A
Alpha-Tocopherol SCHEMBL28434587 0.98 LMNA (0.84) LMNATTPAMAPTMEN1KMT2A
Alpha-Tocopherol SCHEMBL28479098 0.97 LMNA (0.82) LMNATTPAMAPTMEN1KMT2A
Alpha-Tocopherol SCHEMBL27697041 0.97 LMNA (0.82) LMNATTPAMAPTMEN1KMT2A
Alpha-Tocopherol SCHEMBL359306 0.97 LMNA (0.82) LMNATTPAMAPTMEN1KMT2A
Alpha-Tocopherol SCHEMBL369660 0.97 LMNA (0.82) LMNATTPAMAPTMEN1KMT2A
Alpha-Tocopherol SCHEMBL28838443 0.97 LMNA (0.82) LMNATTPAMAPTMEN1KMT2A
Alpha-Tocopherol SCHEMBL358455 0.97 LMNA (0.82) LMNATTPAMAPTMEN1KMT2A
Alpha-Tocopherol SCHEMBL42939 0.97 LMNA (0.86) LMNATTPAMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022224196-A9 ORALLY DISSOLVING FILMS Nicoventures Trading Limited (GB) 2024-07-18 WO disclosed
WO-2024095162-A1 METHOD OF PREPARING A POUCHED PRODUCT COMPRISING A NICOTINE SALT Nicoventures Trading Limited (GB) 2024-05-10 WO disclosed
WO-2024095164-A1 PRODUCTS WITH SPHERICAL FILLER Nicoventures Trading Limited (GB) 2024-05-10 WO disclosed
WO-2024095163-A1 ORAL COMPOSITION COMPRISING ENCAPSULATED PH ADJUSTING AGENT Nicoventures Trading Limited (GB) 2024-05-10 WO disclosed
WO-2024089588-A1 SHAPED POUCHED PRODUCTS Nicoventures Trading Limited (GB) 2024-05-02 WO disclosed
EP-4358747-A1 ORAL PRODUCT TABLET AND METHOD OF MANUFACTURE Nicoventures Trading Limited (GB) 2024-05-01 EP disclosed
EP-4355121-A1 POUCHED PRODUCT COMPRISING DISSOLVABLE COMPOSITION Nicoventures Trading Limited (GB) 2024-04-24 EP disclosed
WO-2024079722-A1 CAPSULE-CONTAINING POUCHED PRODUCTS Nicoventures Trading Limited (GB) 2024-04-18 WO disclosed
EP-4333650-A1 ORAL COMPOSITIONS AND RELATED METHODS FOR REDUCING THROAT IRRITATION Nicoventures Trading Limited (GB) 2024-03-13 EP disclosed
EP-4329526-A1 MULTI-COMPARTMENT ORAL POUCHED PRODUCT Nicoventures Trading Limited (GB) 2024-03-06 EP disclosed
CN-100471886-C Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery SAMYANG CORP (KR) 2009-03-25 CN disclosed
US-20080152616-A1 Amphiphilic block copolymer and polymeric compostition comprising the same for drug delivery SAMYANG HOLDINGS CORPORATION (KR) 2008-06-26 US disclosed
US-7311901-B2 Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery SAMYANG CORPORATION (KR) 2007-12-25 US disclosed
EP-1670838-A1 AMPHIPHILIC BLOCK COPOLYMER AND POLYMERIC COMPOSITION COMPRISING THE SAME FOR DRUG DELIVERY Samyang Corporation (KR) 2006-06-21 EP disclosed
CN-1780865-A Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery SAMYANG CORP (KR) 2006-05-31 CN disclosed
US-20050201972-A1 Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery SAMYANG CORPORATION 2005-09-15 US disclosed
WO-2005035606-A1 AMPHIPHILIC BLOCK COPOLYMER AND POLYMERIC COMPOSITION COMPRISING THE SAME FOR DRUG DELIVERY SAMYANG CORPORATION (KR) 2005-04-21 WO disclosed
US-5610180-A TOCOPHEROL AND CHOLESTEROL DERIVATIVES, CYTOPROTECTIVE AGENTS VIRGINIA COMMONWEALTH UNIVERSITY (US) 1997-03-11 US disclosed
US-5336485-A Administering cholestane phthalates, succinates or sulfates before administering tacrine CENTER FOR INNOVATIVE TECHNOLOGY (US) 1994-08-09 US disclosed
US-5198432-A Cytoprotective agents CENTER FOR INNOVATIVE TECHNOLOGY (US) 1993-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080152616-A1 Amphiphilic block copolymer and polymeric compostition comprising the same for drug delivery CETP, ABCB4, TPRKB LMNA 872/4885TTPA 7/4885MAPT 1426/4885
US-20050201972-A1 Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery TTPA, CETP, CHKB LMNA 322/4885TTPA 1/4885MAPT 1120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.